Larry M. Allen
About
In The Last Decade
Larry M. Allen
34 papers receiving 584 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 300
- Oncology 233
- Pathology and Forensic Medicine 98
- Hematology 93
- Epidemiology 67
Countries citing papers authored by Larry M. Allen
This map shows the geographic impact of Larry M. Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry M. Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry M. Allen more than expected).
Fields of papers citing papers by Larry M. Allen
This network shows the impact of papers produced by Larry M. Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry M. Allen. The network helps show where Larry M. Allen may publish in the future.
Co-authorship network of co-authors of Larry M. Allen
This figure shows the co-authorship network connecting the top 25 collaborators of Larry M. Allen. A scholar is included among the top collaborators of Larry M. Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry M. Allen. Larry M. Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | MTC™ A Magnetically Targetable Drug Carrier for Paclitaxel | 5 |
| 4 | 1 | |
| 5 | 62 | |
| 6 | 46 | |
| 7 | 14 | |
| 8 | Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501). | 5 |
| 9 | 37 | |
| 10 | Correlation of the disposition kinetics and intracellular accumulation of imidazo-pyrazole(nsc-51149) with alterations in ribonucleotide pools and dna distribution content of masto- cytoma cells in vivo. Abstr. | 1 |
| 11 | Comparison of uptake and binding of two epipodophyllotoxin glucopyranosides, 4'-demethyl epipodophyllotoxin thenylidene-beta-D-glucoside and 4'-demethyl epipodophyllotoxin ethylidene-beta-D-glucoside, in the L1210 leukemia cell. | 38 |
| 12 | Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse. | 18 |
| 13 | 30 | |
| 14 | 29 | |
| 15 | 37 | |
| 16 | Thalicarpine (nsc-68075) inhibition of dna, rna, and protein synthesis in cultured mouse leukemia cells (l1210). Abstr. | 1 |
| 17 | 3 | |
| 18 | 27 | |
| 19 | Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075). | 14 |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.